Cargando…
A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries
BACKGROUND: With the rapid development of the genomic sequence data for the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants Delta (B.1.617.2) and Omicron (B.1.1.529), it is vital to successfully identify mutations within the genome. OBJECTIVE: The main objective of the...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262654/ https://www.ncbi.nlm.nih.gov/pubmed/35839568 http://dx.doi.org/10.1016/j.jiph.2022.07.002 |
_version_ | 1784742550840541184 |
---|---|
author | Ahmad, Syed Umair Hafeez Kiani, Bushra Abrar, Muhammad Jan, Zainab Zafar, Imran Ali, Yasir Alanazi, Amer M. Malik, Abdul Rather, Mohd Ashraf Ahmad, Asrar Khan, Azmat Ali |
author_facet | Ahmad, Syed Umair Hafeez Kiani, Bushra Abrar, Muhammad Jan, Zainab Zafar, Imran Ali, Yasir Alanazi, Amer M. Malik, Abdul Rather, Mohd Ashraf Ahmad, Asrar Khan, Azmat Ali |
author_sort | Ahmad, Syed Umair |
collection | PubMed |
description | BACKGROUND: With the rapid development of the genomic sequence data for the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants Delta (B.1.617.2) and Omicron (B.1.1.529), it is vital to successfully identify mutations within the genome. OBJECTIVE: The main objective of the study is to investigate the full-length genome mutation analysis of 157 SARS-CoV-2 and its variant Delta and Omicron isolates. This study also provides possible effects at the structural level to understand the role of mutations and new insights into the evolution of COVID-19 and evaluates the differential level analysis in viral genome sequence among different nations. We have also tried to offer a mutation snapshot for these differences that could help in vaccine formulation. This study utilizes a unique and efficient method of targeting the stable genes for the drug discovery approach. METHODS: Complete genome sequence information of SARS-CoV-2, Delta, and Omicron from online resources were used to predict structure domain identification, data mining, and screening; employing different bioinformatics tools. BioEdit software was used to perform their genomic alignments across countries and a phylogenetic tree as per the confidence of 500 bootstrapping values was constructed. Heterozygosity ratios were determined in-silico. A minimum spanning network (MSN) of selected populations was determined by Bruvo's distance role-based framework. RESULTS: Out of all 157 different strains of SARS-CoV-2 and its variants, and their complete genome sequences from different countries, Corona nucleoca and DUF5515 were observed to be the most conserved domains. All genomes obtained changes in comparison to the Wuhan-Hu-1 strain, mainly in the TRS region (CUAAAC or ACGAAC). We discovered 596 mutations in all genes, with the highest number (321) found in ORF1ab (QHD43415.1), or TRS site mutations found only in ORF7a (1) and ORF10 (2). The Omicron variant has 30 mutations in the Spike protein and has a higher alpha-helix shape (23.46%) than the Delta version (22.03%). T478 was also discovered to be a prevalent polymorphism in Delta and Omicron variations, as well as genomic gaps ranging from 45 to 65aa. All 157 sequences contained variations and conformed to Nei's Genetic distance. We discovered heterozygosity (Hs) 0.01, mean anticipated Hs 0.32, the genetic diversity index (GDI) 0.01943989, and GD within population 0.01266951. The Hedrick value was 0.52324978, the GD coefficient was 0.52324978, the average Hs was 0.01371452, and the GD coefficient was 0.52324978. Among other countries, Brazil has the highest standard error (SE) rate (1.398), whereas Japan has the highest ratio of Nei's gene diversity (0.01). CONCLUSIONS: The study's findings will assist in comprehending the shape and kind of complete genome, their streaming genomic sequences, and mutations in various additions of SARS-CoV-2, as well as its different variant strains like Omicron. These results will provide a scientific basis to design the vaccines and understand the genomic study of these viruses. |
format | Online Article Text |
id | pubmed-9262654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92626542022-07-08 A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries Ahmad, Syed Umair Hafeez Kiani, Bushra Abrar, Muhammad Jan, Zainab Zafar, Imran Ali, Yasir Alanazi, Amer M. Malik, Abdul Rather, Mohd Ashraf Ahmad, Asrar Khan, Azmat Ali J Infect Public Health Original Article BACKGROUND: With the rapid development of the genomic sequence data for the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants Delta (B.1.617.2) and Omicron (B.1.1.529), it is vital to successfully identify mutations within the genome. OBJECTIVE: The main objective of the study is to investigate the full-length genome mutation analysis of 157 SARS-CoV-2 and its variant Delta and Omicron isolates. This study also provides possible effects at the structural level to understand the role of mutations and new insights into the evolution of COVID-19 and evaluates the differential level analysis in viral genome sequence among different nations. We have also tried to offer a mutation snapshot for these differences that could help in vaccine formulation. This study utilizes a unique and efficient method of targeting the stable genes for the drug discovery approach. METHODS: Complete genome sequence information of SARS-CoV-2, Delta, and Omicron from online resources were used to predict structure domain identification, data mining, and screening; employing different bioinformatics tools. BioEdit software was used to perform their genomic alignments across countries and a phylogenetic tree as per the confidence of 500 bootstrapping values was constructed. Heterozygosity ratios were determined in-silico. A minimum spanning network (MSN) of selected populations was determined by Bruvo's distance role-based framework. RESULTS: Out of all 157 different strains of SARS-CoV-2 and its variants, and their complete genome sequences from different countries, Corona nucleoca and DUF5515 were observed to be the most conserved domains. All genomes obtained changes in comparison to the Wuhan-Hu-1 strain, mainly in the TRS region (CUAAAC or ACGAAC). We discovered 596 mutations in all genes, with the highest number (321) found in ORF1ab (QHD43415.1), or TRS site mutations found only in ORF7a (1) and ORF10 (2). The Omicron variant has 30 mutations in the Spike protein and has a higher alpha-helix shape (23.46%) than the Delta version (22.03%). T478 was also discovered to be a prevalent polymorphism in Delta and Omicron variations, as well as genomic gaps ranging from 45 to 65aa. All 157 sequences contained variations and conformed to Nei's Genetic distance. We discovered heterozygosity (Hs) 0.01, mean anticipated Hs 0.32, the genetic diversity index (GDI) 0.01943989, and GD within population 0.01266951. The Hedrick value was 0.52324978, the GD coefficient was 0.52324978, the average Hs was 0.01371452, and the GD coefficient was 0.52324978. Among other countries, Brazil has the highest standard error (SE) rate (1.398), whereas Japan has the highest ratio of Nei's gene diversity (0.01). CONCLUSIONS: The study's findings will assist in comprehending the shape and kind of complete genome, their streaming genomic sequences, and mutations in various additions of SARS-CoV-2, as well as its different variant strains like Omicron. These results will provide a scientific basis to design the vaccines and understand the genomic study of these viruses. The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2022-08 2022-07-08 /pmc/articles/PMC9262654/ /pubmed/35839568 http://dx.doi.org/10.1016/j.jiph.2022.07.002 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Ahmad, Syed Umair Hafeez Kiani, Bushra Abrar, Muhammad Jan, Zainab Zafar, Imran Ali, Yasir Alanazi, Amer M. Malik, Abdul Rather, Mohd Ashraf Ahmad, Asrar Khan, Azmat Ali A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries |
title | A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries |
title_full | A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries |
title_fullStr | A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries |
title_full_unstemmed | A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries |
title_short | A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries |
title_sort | comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of sars-cov-2 and its variant omicron among different countries |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262654/ https://www.ncbi.nlm.nih.gov/pubmed/35839568 http://dx.doi.org/10.1016/j.jiph.2022.07.002 |
work_keys_str_mv | AT ahmadsyedumair acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT hafeezkianibushra acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT abrarmuhammad acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT janzainab acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT zafarimran acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT aliyasir acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT alanaziamerm acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT malikabdul acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT rathermohdashraf acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT ahmadasrar acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT khanazmatali acomprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT ahmadsyedumair comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT hafeezkianibushra comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT abrarmuhammad comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT janzainab comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT zafarimran comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT aliyasir comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT alanaziamerm comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT malikabdul comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT rathermohdashraf comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT ahmadasrar comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries AT khanazmatali comprehensivegenomicstudymutationscreeningphylogeneticandstatisticalanalysisofsarscov2anditsvariantomicronamongdifferentcountries |